E
Orchestra BioMed Holdings, Inc. OBIO
$2.60 $0.051.96% NASDAQ
Recommendation
Prev Close
$2.55
Volume
127,099
Avg Vol (90D)
457,781
Market Cap
$137.59M
Dividend & Yield
--
52-Week Range
$2.37 - $7.04
P/E (TTM)
--
EPS (TTM)
-$1.83
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Orchestra BioMed (NASDAQ:OBIO) Given "Neutral" Rating at BTIG Research
8/22/2025 - MarketBeat
Equities Analysts Offer Predictions for OBIO FY2025 Earnings
8/19/2025 - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Given "Buy" Rating at Chardan Capital
8/15/2025 - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Issues Earnings Results, Beats Estimates By $0.01 EPS
8/14/2025 - MarketBeat
Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
8/14/2025 - Globe Newswire
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates
8/12/2025 - Zacks Investment Research
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
8/12/2025 - Globe Newswire
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives $14.00 Average PT from Analysts
8/11/2025 - Ticker Report
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
8/8/2025 - Globe Newswire
David P. Hochman Acquires 20,000 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock
8/6/2025 - Ticker Report
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Buy" by Analysts
8/6/2025 - MarketBeat
David P. Hochman Purchases 20,000 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock
8/5/2025 - MarketBeat
Orchestra BioMed (OBIO) Projected to Post Earnings on Monday
8/5/2025 - MarketBeat
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
8/5/2025 - Globe Newswire
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Acquires 20,000 Shares of Stock
8/5/2025 - MarketBeat
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates
8/4/2025 - Zacks Investment Research
Orchestra BioMed Holdings Closes $40M Public Offering
8/4/2025 - TipRanks Financial Blog
Orchestra BioMed Announces Pricing of $40 Million Public Offering
8/1/2025 - Globe Newswire
Orchestra BioMed Announces Proposed Public Offering
7/31/2025 - Globe Newswire
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
7/31/2025 - Globe Newswire
IFP Advisors Inc Acquires 83,481 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)
7/25/2025 - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Recommendation of "Buy" by Brokerages
7/17/2025 - Ticker Report
The Math Shows DFAC Can Go To $40
7/16/2025 - ETF Channel
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Buy" by Brokerages
7/12/2025 - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% - Here's What Happened
7/10/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$2.94M
EBITDA (TTM)
-$70.94M
EBIT (TTM)
-$71.27M
Net Income (TTM)
-$69.70M
Balance Sheet
Total Assets (Q)
$42.83M
Total Debt (Q)
$16.35M
Total Liabilities (Q)
$42.53M
Book Value Per Share (Q)
$0.0076
Cash Flow
Cash from Operations (TTM)
-$59.38M
Cash from Investing (TTM)
$26.16M
Cash from Financing (TTM)
$28.26M
Net Change in Cash (TTM)
-$4.96M
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
1.81
7-Day Total Return
-2.26%
30-Day Total Return
-14.19%
60-Day Total Return
-8.13%
90-Day Total Return
-7.80%
Year to Date Total Return
-51.67%
1-Year Total Return
-60.73%
2-Year Total Return
-62.54%
3-Year Total Return
-73.75%
5-Year Total Return
-76.79%
52-week Low
May 07, 2025 - $2.37
52-week High
Aug 29, 2024 - $7.04
Valuation
Market Cap
$137.59M - Micro Cap
Enterprise Value
$120.02M
Price/Sales (TTM)
33.29
Price/Book (Q)
335.53
Dividends and Shares
Shares Outstanding
38.39
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
orchestrabiomed.com
Phone Number
215 862 5797
Address
150 Union Square Drive
New Hope, PA 18938
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company’s flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic... more
NASDAQ 08/25/2025 4:00PM Eastern Quotes delayed